Author:
Park Jeong-eun,Zhang Luying,Ho Yu-Fan,Liu Ge,Alfonso-Cristancho Rafael,Ismaila Afisi S.,Zafari Zafar
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)
Reference32 articles.
1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global initiative for chronic obstructive lung disease (2021 report). Global Initiative for Chronic Obstructive Lung Disease. https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed February 23, 2021.
2. Health-related quality of life in patients by COPD severity within primary care in Europe;Jones;Respir Med,2011
3. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
4. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015;Soriano;Lancet Respir Med,2017
5. A subnational analysis of mortality and prevalence of COPD in China from 1990 to 2013;Yin;Chest,2016
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献